High prevalence and interrelated psychological distress among patients with early-stage papillary thyroid carcinoma
Eurasian Journal of Medicine and Oncology · 04.06.2026 · 026030035
DOI: 10.36922/ejmo026030035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 04.06.2026. Verfasst von Wanru Qiu und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Papillary thyroid carcinoma (PTC) has an excellent survival prognosis, yet a growing body of evidence suggests survivors bear a significant psychosocial burden. The multidimensional psychological profile and the interrelationships between specific distress factors in early-stage PTC patients remain inadequately characterized.
Objective
This study aimed to quantify psychological distress in early-stage PTC patients compared to healthy controls (HCs) and to explore the correlational network among anxiety, depression, fear of progression, stigma, shame, and self-esteem within the patient group.
Methods
In this cross-sectional study, 14 patients with early-stage PTC and 15 age- and sex-matched HCs were enrolled. Psychological assessment was performed using clinician-administered (Hamilton Anxiety Rating Scale [HAMA] and Hamilton Depression Rating Scale [HAMD]) and self-report scales (Self-Rating Anxiety Scale [SAS], Self-Rating Depression Scale [SDS], Pittsburgh Sleep Quality Index [PSQI], Beck Scale for Suicidal Ideation, Fear of Progression Questionnaire-Short Form [FoP-Q-SF], Social Impact Scale [SIS], Shame and Stigma Scale in Head and Neck Cancer Patients [SSS-HNC], Self-Esteem Scale [SES], and Perceived Social Support Scale). Group comparisons were made using t-tests, and Pearson correlations were analyzed within the PTC group.
Results
Compared to HCs, PTC patients reported significantly higher levels of anxiety (HAMA: 10.07 ± 6.03 vs. 0.67 ± 1.11, p < 0.001; SAS: 5.09 ± 1.36 vs. 1.03 ± 0.27, p < 0.001), depression (HAMD: 8.29 ± 4.70 vs. 1.33 ± 2.29, p < 0.001; SDS: 3.39 ± 0.91 vs. 0.53 ± 0.64, p < 0.001), and sleep disturbance (PSQI: 6.36 ± 4.72 vs. 3.47 ± 1.81, p < 0.001). Correlation analysis revealed strong associations between clinician-rated and self-reported anxiety (HAMA–SAS: r = 0.77) and between anxiety and depression (HAMA–HAMD: r = 0.83). Fear of progression was positively correlated with clinician-rated anxiety (FoP-Q-SF–HAMA: r = 0.53). Notably, both self-esteem (SES) and perceived social stigma (SIS) showed negative correlations with internalized shame (SSS-HNC) (r = −0.54 and r = −0.42, respectively).
Conclusion
Patients with early-stage PTC experience a significant and interconnected burden of psychological distress. The counterintuitive finding of lower perceived stigma correlating with higher internalized shame suggests a unique psychosocial dynamic in this population, likely influenced by the “good cancer” narrative. These preliminary findings highlight the potential value of integrated psychological assessment and tailored supportive care in PTC survivorship and require further validation in larger-scale studies.
Zitieren
APA
Qiu, W., Tang, D., Zhang, A., Li, S., & Zhou, C. (2026). High prevalence and interrelated psychological distress among patients with early-stage papillary thyroid carcinoma. Eurasian Journal of Medicine and Oncology, 0(0), 026030035. https://doi.org/10.36922/ejmo026030035
Vancouver
Qiu W, Tang D, Zhang A, Li S, Zhou C. High prevalence and interrelated psychological distress among patients with early-stage papillary thyroid carcinoma. Eurasian Journal of Medicine and Oncology. 2026;0(0):026030035. doi:10.36922/ejmo026030035
BibTeX
@article{Qiu2026,
author = {Qiu, Wanru and Tang, Desheng and Zhang, Aoxue and Li, Sen and Zhou, Cong},
title = {High prevalence and interrelated psychological distress among patients with early-stage papillary thyroid carcinoma},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {026030035},
doi = {10.36922/ejmo026030035}
}
EUVIMED